Moving forward in colorectal cancer research, what proteomics has to tell

查看全文 作　　者：Nerea [1]Bitarte;Eva [1]Bandrés;Ruth [1]Zárate;Natalia [1]Ramirez;Jesus Garcia-[1]Foncillas

机构地区：[1]Laboratory of Pharmacogenomics, Center for Medical Applied Research, Unit of Clinical Genetics, University Clinic, Department of Oncology and Radiotherapy, University Clinic, University of Navarra, Pamplona 31008, Spain

出　　处：《World Journal of Gastroenterology》索引2007年第13卷第44期,共9页

摘　　要：Colorectal cancer is the third most common cancer and is highly fatal. During the last several years, research has been primarily based on the study of expression profiles using microarray technology. But now, investigators are putting into practice proteomic analyses of cancer tissues and cells to identify new diagnostic or therapeutic biomarkers for this cancer. Because the proteome reflects the state of a cell, tissue or organism more accurately, much is expected from proteomics to yield better tumor markers for disease diagnosis and therapy monitoring. This review summarizes the most relevant applications of proteomics the biomarker discovery for colorectal cancer. 关键词：结肠癌高致命性癌细胞治疗方法

相关文献

参考文献（49）
引证文献（3）
耦合文献（0）

参考文献(49)

引证文献(3)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Moving forward in colorectal cancer research, what proteomics has to tell

参考文献(49)

引证文献(3)

用户提示